NF-κB/p52 augments ETS1 binding genome-wide to promote glioma progression
Abstract Gliomas are highly invasive and chemoresistant cancers, making them challenging to treat. Chronic inflammation is a key driver of glioma progression as it promotes aberrant activation of inflammatory pathways such as NF-κB signalling, which drives cancer cell invasion and angiogenesis. NF-κ...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-04-01
|
| Series: | Communications Biology |
| Online Access: | https://doi.org/10.1038/s42003-023-04821-2 |